
Evaluating impact of symptom management on quality of life in glioma patients
Publication
, Conference
Allen, DH; Carter, K; Jackson, S; Ziegler, K; Affronti, ML; Dunn, R; Guill, B
Published in: NEURO-ONCOLOGY
October 1, 2004
Duke Scholars
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
October 1, 2004
Volume
6
Issue
4
Start / End Page
355 / 355
Location
Toronto, CANADA
Publisher
DUKE UNIV PRESS
Conference Name
9th Annual Meeting of the Society-for-Neuro-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Allen, D. H., Carter, K., Jackson, S., Ziegler, K., Affronti, M. L., Dunn, R., & Guill, B. (2004). Evaluating impact of symptom management on quality of life in glioma patients. In NEURO-ONCOLOGY (Vol. 6, pp. 355–355). Toronto, CANADA: DUKE UNIV PRESS.
Allen, D. H., K. Carter, S. Jackson, K. Ziegler, M. L. Affronti, R. Dunn, and B. Guill. “Evaluating impact of symptom management on quality of life in glioma patients.” In NEURO-ONCOLOGY, 6:355–355. DUKE UNIV PRESS, 2004.
Allen DH, Carter K, Jackson S, Ziegler K, Affronti ML, Dunn R, et al. Evaluating impact of symptom management on quality of life in glioma patients. In: NEURO-ONCOLOGY. DUKE UNIV PRESS; 2004. p. 355–355.
Allen, D. H., et al. “Evaluating impact of symptom management on quality of life in glioma patients.” NEURO-ONCOLOGY, vol. 6, no. 4, DUKE UNIV PRESS, 2004, pp. 355–355.
Allen DH, Carter K, Jackson S, Ziegler K, Affronti ML, Dunn R, Guill B. Evaluating impact of symptom management on quality of life in glioma patients. NEURO-ONCOLOGY. DUKE UNIV PRESS; 2004. p. 355–355.

Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
October 1, 2004
Volume
6
Issue
4
Start / End Page
355 / 355
Location
Toronto, CANADA
Publisher
DUKE UNIV PRESS
Conference Name
9th Annual Meeting of the Society-for-Neuro-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences